These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10408415)

  • 1. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.
    Zhai YL; Nikaido T; Toki T; Shiozawa A; Orii A; Fujii S
    Br J Cancer; 1999 Jul; 80(10):1658-64. PubMed ID: 10408415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.
    Jeffers MD; Farquharson MA; Richmond JA; McNicol AM
    J Pathol; 1995 Sep; 177(1):65-70. PubMed ID: 7472782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.
    Leiser AL; Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi DS; Soslow RA
    Gynecol Oncol; 2006 Apr; 101(1):86-91. PubMed ID: 16289259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of bcl-2 and bax protein in uterine leiomyosarcomas and leiomyomas].
    Zhang ZL; Zhang Y; Zhou JH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):183-6. PubMed ID: 15898430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
    Jeffers MD; Richmond JA; Macaulay EM
    Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas.
    Shpitz B; Tiomkin V; Bomstein Y; Gralkin M; Buklan H; Bernheim J; Klein E
    Eur J Surg Oncol; 2001 Mar; 27(2):203-8. PubMed ID: 11289760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
    Swellam M; Ismail M; Eissa S; Hamdy M; Mokhtar N
    IUBMB Life; 2004 Aug; 56(8):483-90. PubMed ID: 15545228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
    Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
    Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
    Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
    Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
    Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
    Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S; Nakano H; Tsuneyoshi M
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of P53 protein expression in gastrointestinal smooth muscle tumors. Clinicopathological correlation and prognostic significance.
    Cai J; Jiang Y; Zhang Y; Lu G; Zhang X; Gao Q; Zuo L
    Chin Med J (Engl); 1995 Sep; 108(9):669-73. PubMed ID: 8575232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
    Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
    Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma.
    Uzunlar AK; Sahin H; Yilmaz F; Ozekinci S
    Saudi Med J; 2005 Jan; 26(1):37-41. PubMed ID: 15756350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.
    Sahu GR; Das BR
    Oncol Rep; 2002; 9(6):1391-8. PubMed ID: 12375054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.